Table 1.
Tabulation of laboratory parameters
| Laboratory parameters | Values in unit (normal range) on admission | Values in unit (normal range) 7 weeks later |
| Haemoglobin | 73 g/L (130–180) | 102 g/L (130–180) |
| Mean Corpuscular Volume | 90.6 fL (83–101) | 93.4 fL (83–101) |
| Mean Corpuscular Haemoglobin Concentration | 33.3 g/dL (31.5–34.5) | 33 g/dL (31.5–34.5) |
| White cell count | 11.6×109 /L (4–10) | 7.63×109 /L (4–10) |
| Platelets | 292×103 /µL (150–400) | 280×103 /µL (150–400) |
| aPTT | 78.7 s (25.4–38.4) | 27.1 s (25.4–38.4) |
| Prothrombin time (PT) | 13.1 s (9.62–12.18) | 10.6 s (9.62–12.18) |
| International normalised ratio | 1.26 | 0.97 |
| Creatinine | 134 umol/L (45–84) | – |
| Serum albumin | 31 g/L (35–52) | – |
| Carcinoembryonic antigen | 6.2 ng/mL (<3) | – |
| Carbohydrate antigen (CA 19–9) | <2 U/mL (<37) | – |
| Alpha fetoprotein | 1.5 ng/mL (<9) | – |
| Prostate-specific antigen | 9.234 ng/mL (<4) | – |
| Antinuclear antibodies | Negative | – |
| Beta-hCG (human chorionic gonadotropin) | 2.1 IU/L (<5) | – |
| C reactive protein | 8.8 mg/L (<5) | – |
| Total iron binding capacity | 41.4 umol/L | – |
| Serum iron | 7.6 umol/L | – |
| Unsaturated iron-binding capacity | 33.8 umol/L | – |
| Serum vitamin B12 level | 103 pmol/L (133–675) | – |
| Serum folate level | 12.9 nmol/L (>14.93) | – |
| Peripheral blood film | Anaemia with increased reticulocytes possibly secondary to underlying bleeding/blood loss. No evidence of haemolysis was seen. White blood cell changes suggest infection or inflammation. | – |
| FVIII assay | 6.7% (50–150) | 365.1% (50–150) |
| FVIII inhibitor | 7.5 BU | <0.5 BU |
| Factor IX assay | 114.7% (86.4–128.4) | – |
aPTT, activated partial thromboplastin time; FVIII, factor VIII.